ALPHAMAB ONCOLOGY

Alphamab Oncology is a biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization of world-class innovative biotherapeutics for cancer treatment. On December 12, 2019, Alphamab Oncology was listed on the Main Board of Hong Kong Stock Exchange, with the stock code:9966... With advanced technology platforms, Alphamab Oncology has established a globally competitive and differentiated pipeline which covers single domain antibody/monoclonal antibodies, multi-functional antibodies, and antibody-drug conjugates.